Health Condition 1: N921- Excessive and frequent menstruation with irregular cycle
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are willing to participate in the trial, including both married and unmarried individuals, will be included. The primary eligibility criterion is the presence of Asrigdara as a cardinal symptom. Additionally, the study will consider patients within the age range of 18 to 45 years.
Exclusion criteria
Exclusion criteria: Patients who are not willing to participate in the trial will be excluded. Additionally, individuals with hemoglobin levels below 8 gm%, pregnant patients, and lactating women will not be considered. Those using intrauterine contraceptive devices (IUCDs) or oral contraceptive pills (OCPs) are also ineligible. Exclusion criteria further include bleeding from sites other than the uterus, bleeding due to abortion, postmenopausal bleeding, and systemic illnesses such as severe hypertension, liver dysfunction, thyroid disorders, and sexually transmitted diseases (STDs). Patients with coagulation disorders or those diagnosed with uterine and pelvic pathologies, including fibroids, adenomyosis, pelvic inflammatory disease (PID), endometrial polyps, and cervical cancer, will also be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Normalization of Menstrual Cycle 2.Reduction in Spotting or Pre-menstrual BleedingTimepoint: 3 Months | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in associate symptoms like angamarda kathishool aruchi daurbalya bhram tamoPravesh tandra etcTimepoint: 3 Months | — |
Countries
India
Contacts
Government Ayurvedic PG College And Hospital Chaukaghat, Varanasi